For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Understanding varicose veins; what are the new treatment options?
+Practice
In print
VASCULAR MEDICINE
Understanding varicose veins; what are the new treatment options?
Thursday 23 November 2017, 10:01 AM

The risk of developing varicose veins is strongly familial
The use of surgery in treating varicose veins has greatly dwindled as a range of day-stay options have become available; but which one is right for your patient?
EVTA is now widely considered to be the gold standard technique for treating superficial venous disease
Varicose veins affect around 25 per cent , Clinical grading - varicose veins, Clinical grading system for venous disease
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.